Sign inJoin waitlistJoin the waitlist

Elan Gorshein

, Assistant Professor of Medicine (Hematology), in the Academic Clinician Track · Yale-New Haven Hospital

Credentials: · · · · · · ·

History

Yale-New Haven Hospital
Present
Yale School of Medicine
Present

Hematology and Medical Oncology
2015–2018
Rutgers University School of Law
2012–2015
Johns Hopkins Bloomberg School of Public Health
Rowan University
2008–2012

Research

Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell…
Clinical Transplantation · 2017 · First of 16 authors · 65 citations
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
Case report · Case Reports in Oncology · 2021 · First of 13 authors · 16 citations
Clinical significance of HER2-positive and triple-negative status in small (≤ 1 cm) node-negative breast cancer
Clinical Breast Cancer · 2014 · First of 4 authors · 12 citations

MG
Mecide Gharibo
2 papers
Sabrina Browning
2 papers
Alankrita Taneja
1 paper
Alexa Siddon
1 paper
AL
Alexander Lesokhin
1 paper
AL
Alfred Lee
1 paper
Amay Parikh
1 paper · 1 as a fellow
Anna Ferrari
1 paper
BB
Burak Bahar
1 paper
Catherine Wei
1 paper · 1 as a fellow
Christopher Tormey
1 paper
CT
Cynthia Thomson
1 paper

Clinical trials

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2024–2026
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2031